Andrew Murphy

Has grant

Associate Professor

Baker Heart and Diabetes Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrew Murphy is an Associate Professor at the Baker Heart and Diabetes Institute in Australia. His research focuses on the roles of iron, lipid peroxidation, and ferroptosis in atherosclerosis, as well as the influence of metabolic disorders on adaptive immunity. Recent publications also explore immunometabolism in cardiovascular diseases and the effects of atorvastatin on vascular health in type 2 diabetes patients.

Recent Grants

Grant: Close

NLRP1 and obesity

Open Date: 2018-01-01

Close Date: 2020-01-01

Grant: Close

Targeting dysfunctional mitochondria in macrophages to inhibit atherosclerosis

Open Date: 2018-01-01

Close Date: 2021-01-01

Grant: Close

S100A8/A9 as a target in metabolic diseases to inhibit the acceleration of cardiovascular disease

Open Date: 2016-01-01

Close Date: 2018-01-01

Grant: Close

Investigation into the intervention of arterial thrombosis and atherosclerosis using shear sensitive nanoparticle drug delivery

Open Date: 2015-01-01

Close Date: 2018-12-31

Grant: Close

Haematopoiesis, Metabolic Disorders and Atherosclerosis

Open Date: 2015-01-01

Close Date: 2018-12-31

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (15)

Raymond K H Yip

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

Andrew Murphy

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Iron, lipid peroxidation, and ferroptosis play pathogenic roles in atherosclerosis

Do physiological changes in fatty acid composition alter cellular ferroptosis susceptibility and influence cell function?

GPX4 methylation puts a brake on ferroptosis

Immunometabolism in atherosclerotic disorders

Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells

The influence of metabolic disorders on adaptive immunity

Iron Macrophages: Dance of Death and MMP Release in Intraplaque Hemorrhage

Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes

TP53 clonal hematopoiesis promotes atherosclerosis

Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?

Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis

Immune-based therapies in cardiovascular and metabolic diseases: past, present and future

DAMPening Mortality in COVID-19

Mitochondria orchestrate macrophage effector functions in atherosclerosis

Apo AI Nanoparticles Delivered Post Myocardial Infarction Moderate Inflammation

NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction

Collaborators (15)

Raymond K H Yip

Dmitri Sviridov

Nicole La Gruta

Adélie DUMONT

Marc R Dweck

Nordin M.J. Hanssen

Prabhakara Nagareddy

Andrew Fleetwood

Bart Spaetgens

Nick S Nurmohamed

Mark A Febbraio

aldons lusis

Jeffrey Kroon

Albert DAHDAH

Bhupinder Pal

Make your next move.